Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis

Acute respiratory distress syndrome (ARDS) is a serious lung condition characterized by severe hypoxemia leading to limitations of oxygen needed for lung function. In this study, we investigated the effect of anandamide (AEA), an endogenous cannabinoid, on Staphylococcal enterotoxin B (SEB)-mediated...

Full description

Bibliographic Details
Main Authors: Muthanna Sultan, Kiesha Wilson, Osama A. Abdulla, Philip Brandon Busbee, Alina Hall, Taylor Carter, Narendra Singh, Saurabh Chatterjee, Prakash Nagarkatti, Mitzi Nagarkatti
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/12/3305
_version_ 1797505996098109440
author Muthanna Sultan
Kiesha Wilson
Osama A. Abdulla
Philip Brandon Busbee
Alina Hall
Taylor Carter
Narendra Singh
Saurabh Chatterjee
Prakash Nagarkatti
Mitzi Nagarkatti
author_facet Muthanna Sultan
Kiesha Wilson
Osama A. Abdulla
Philip Brandon Busbee
Alina Hall
Taylor Carter
Narendra Singh
Saurabh Chatterjee
Prakash Nagarkatti
Mitzi Nagarkatti
author_sort Muthanna Sultan
collection DOAJ
description Acute respiratory distress syndrome (ARDS) is a serious lung condition characterized by severe hypoxemia leading to limitations of oxygen needed for lung function. In this study, we investigated the effect of anandamide (AEA), an endogenous cannabinoid, on Staphylococcal enterotoxin B (SEB)-mediated ARDS in female mice. Single-cell RNA sequencing data showed that the lung epithelial cells from AEA-treated mice showed increased levels of antimicrobial peptides (AMPs) and tight junction proteins. MiSeq sequencing data on 16S RNA and LEfSe analysis demonstrated that SEB caused significant alterations in the microbiota, with increases in pathogenic bacteria in both the lungs and the gut, while treatment with AEA reversed this effect and induced beneficial bacteria. AEA treatment suppressed inflammation both in the lungs as well as gut-associated mesenteric lymph nodes (MLNs). AEA triggered several bacterial species that produced increased levels of short-chain fatty acids (SCFAs), including butyrate. Furthermore, administration of butyrate alone could attenuate SEB-mediated ARDS. Taken together, our data indicate that AEA treatment attenuates SEB-mediated ARDS by suppressing inflammation and preventing dysbiosis, both in the lungs and the gut, through the induction of AMPs, tight junction proteins, and SCFAs that stabilize the gut-lung microbial axis driving immune homeostasis.
first_indexed 2024-03-10T04:26:18Z
format Article
id doaj.art-e97990a5673844a6b7c2e09639c3e2f6
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T04:26:18Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e97990a5673844a6b7c2e09639c3e2f62023-11-23T07:35:57ZengMDPI AGCells2073-44092021-11-011012330510.3390/cells10123305Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung AxisMuthanna Sultan0Kiesha Wilson1Osama A. Abdulla2Philip Brandon Busbee3Alina Hall4Taylor Carter5Narendra Singh6Saurabh Chatterjee7Prakash Nagarkatti8Mitzi Nagarkatti9Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USAEnvironmental Health and Disease Laboratory, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USADepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USAAcute respiratory distress syndrome (ARDS) is a serious lung condition characterized by severe hypoxemia leading to limitations of oxygen needed for lung function. In this study, we investigated the effect of anandamide (AEA), an endogenous cannabinoid, on Staphylococcal enterotoxin B (SEB)-mediated ARDS in female mice. Single-cell RNA sequencing data showed that the lung epithelial cells from AEA-treated mice showed increased levels of antimicrobial peptides (AMPs) and tight junction proteins. MiSeq sequencing data on 16S RNA and LEfSe analysis demonstrated that SEB caused significant alterations in the microbiota, with increases in pathogenic bacteria in both the lungs and the gut, while treatment with AEA reversed this effect and induced beneficial bacteria. AEA treatment suppressed inflammation both in the lungs as well as gut-associated mesenteric lymph nodes (MLNs). AEA triggered several bacterial species that produced increased levels of short-chain fatty acids (SCFAs), including butyrate. Furthermore, administration of butyrate alone could attenuate SEB-mediated ARDS. Taken together, our data indicate that AEA treatment attenuates SEB-mediated ARDS by suppressing inflammation and preventing dysbiosis, both in the lungs and the gut, through the induction of AMPs, tight junction proteins, and SCFAs that stabilize the gut-lung microbial axis driving immune homeostasis.https://www.mdpi.com/2073-4409/10/12/3305acute respiratory distress syndrome (ARDS)Staphylococcus enterotoxin B (SEB)anandamide (AEA)COVID-19microbiomeMiSeq sequencing
spellingShingle Muthanna Sultan
Kiesha Wilson
Osama A. Abdulla
Philip Brandon Busbee
Alina Hall
Taylor Carter
Narendra Singh
Saurabh Chatterjee
Prakash Nagarkatti
Mitzi Nagarkatti
Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
Cells
acute respiratory distress syndrome (ARDS)
Staphylococcus enterotoxin B (SEB)
anandamide (AEA)
COVID-19
microbiome
MiSeq sequencing
title Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
title_full Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
title_fullStr Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
title_full_unstemmed Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
title_short Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
title_sort endocannabinoid anandamide attenuates acute respiratory distress syndrome through modulation of microbiome in the gut lung axis
topic acute respiratory distress syndrome (ARDS)
Staphylococcus enterotoxin B (SEB)
anandamide (AEA)
COVID-19
microbiome
MiSeq sequencing
url https://www.mdpi.com/2073-4409/10/12/3305
work_keys_str_mv AT muthannasultan endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT kieshawilson endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT osamaaabdulla endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT philipbrandonbusbee endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT alinahall endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT taylorcarter endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT narendrasingh endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT saurabhchatterjee endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT prakashnagarkatti endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis
AT mitzinagarkatti endocannabinoidanandamideattenuatesacuterespiratorydistresssyndromethroughmodulationofmicrobiomeinthegutlungaxis